Drug class
Topical fluoroquinolone antibacterial; DNA gyrase and topoisomerase IV inhibitor
Mechanism of action
Inhibits bacterial DNA gyrase and topoisomerase IV, preventing DNA replication and transcription. It has activity against a range of Gram-positive and Gram-negative skin pathogens, including Cutibacterium acnes and Staphylococcus aureus.
General use cases
- Topical treatment of acne vulgaris and selected superficial bacterial skin infections caused by susceptible organisms in markets where nadifloxacin is authorised.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
